Inferra AI / Company / AVAH
Aveanna Healthcare Holdings, Inc.
AVAH · Health Care
Last earnings Aug 13, 2026
Key results
Revenuequarter
$589.6 million
Revenue was $589.6 million, a 16.8% increase over the prior year period •
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Net incomequarter
$27.0 million
Net income was $27.0 million, a 94.3% increase over the prior year period •
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
The quarter was highlighted by revenue and adjusted EBITDA growth of 16.8% and 93.6%, respectively, when compared to the prior year period.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
” Three-Month Periods Ended June 28, 2025 and June 29, 2024 Revenue was $589.6 million for the three-month period ended June 28, 2025, as compared to $505.0 million for the three-month period ended June 29, 2024, an increase of $84.6 million, or 16.8%.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Gross marginquarter
$210.8 million
Gross margin was $210.8 million, or 35.8% of revenue, for the three-month period ended June 28, 2025, as compared to $158.3 million, or 31.3% of revenue, for the three-month period ended June 29, 2024, an increase of $52.5 million, or 33.2%.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Net income was $27.0 million for the three-month period ended June 28, 2025, as compared to net income of $13.9 million for the three-month period ended June 29, 2024.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Net income per diluted share was $0.13 for the three-month period ended June 28, 2025, as compared to net income per diluted share of $0.07 for the three-month period ended June 29, 2024.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Adjusted net incomequarter
$0.18
Adjusted net income per diluted share was $0.18 for the three-month period ended June 28, 2025, as compared to adjusted net income per diluted share of $0.01 for the three-month period ended June 29, 2024.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
AI analysis
Q2 2025 · reported Aug 7, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
The quarter in charts
Guidance ladder — revenue
Delivered vs the company's guided range
EX-99 · Aug 7, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.
Headline figures
| Metric | Q2 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Revenue | $589.6 million | — | — |
| Net income | $27.0 million | — | — |
| Gross margin | $210.8 million | — | — |
| Adjusted net income | $0.18 | — | — |
Guidance · company-stated
Direction: Raised
“Based on our performance and the opportunities ahead, we are pleased to raise our full-year 2025 guidance to revenue of greater than $2.3 billion and Adjusted EBITDA of greater than $270 million.”
Classified from the release's primary full-year outlook statement.
Margin
Capital allocation
Liquidity, Cash Flow, and Debt • As of June 28, 2025, we had cash of $100.7 million and incremental borrowing capacity of $106.3 million under our securitization facility.
Our revolver was undrawn, with approximately $147.0 million of borrowing capacity and approximately $23.3 million of outstanding letters of credit.
What changed vs last quarter
- Guide midpoint vs latest-quarter revenue +290.1% computed from stated figures
Event summary
Jeff Shaner, Chief Executive Officer, commented, “Our second quarter results reflect the continued positive momentum in all three operating divisions as we navigate the third year of our Strategic Transformation
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Raised
Revenue: “Based on our performance and the opportunities ahead, we are pleased to raise our full-year 2025 guidance to revenue of greater than $2.3 billion and Adjusted EBITDA of greater than $270 million.”
Revenue — Raised (“raise”)
“Based on our performance and the opportunities ahead, we are pleased to raise our full-year 2025 guidance to revenue of greater than $2.3 billion and Adjusted EBITDA of greater than $270 million.”
Classified from the release's primary full-year outlook statement.
Capital allocation
Liquidity, Cash Flow, and Debt • As of June 28, 2025, we had cash of $100.7 million and incremental borrowing capacity of $106.3 million under our securitization facility.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Our revolver was undrawn, with approximately $147.0 million of borrowing capacity and approximately $23.3 million of outstanding letters of credit.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
• As of June 28, 2025 we had bank debt of $1,469.7 million.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Our interest rate exposure under our credit facilities is currently hedged with the following instruments: o $520.0 million notional amount of interest rate swaps that convert variable rate debt to a fixed rate, and o $880.0 million notional amount of interest rate caps that cap our exposure to SOFR at 2.96%.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Adjusted net income (loss) and Adjusted net income (loss) per diluted share Adjusted net income (loss) represents net income (loss) as adjusted for the impact of GAAP income tax, goodwill, intangible and other long-lived asset impairment charges, non-cash share-based compensation expense, loss on extinguishment of debt, interest rate derivatives, acquisition-related costs, integration costs, legal costs, restructuring costs, other legal matters, other system transition costs, professional fees and certain other miscellaneous items on a pre-tax basis.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
We believe free cash flow is helpful in highlighting the cash generated or used by the Company, after taking into consideration mandatory payments on term loans, notes payable and financing leases, as well as cash needed for non-acquisition related capital expenditures, and cash paid to or received from derivative counterparties.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Strategy & priorities
(NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended June 28, 2025.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Jeff Shaner, Chief Executive Officer, commented, “Our second quarter results reflect the continued positive momentum in all three operating divisions as we navigate the third year of our Strategic Transformation.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
The acquisition of Thrive Skilled Pediatric Care illustrates our commitment to investing in current markets and new market expansion to facilitate growth of our core services.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Our team’s relentless focus on operational excellence, disciplined execution, and delivering strong clinical outcomes continues to drive our improved results.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
All statements (other than statements of historical facts) in this press release regarding our prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward-looking statements.
SEC original ↗Aveanna Healthcare Holdings, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Risks & headwinds
Legal Proceedings 41 Item 1A.
SEC original ↗Aveanna Healthcare Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
Exhibits 41 SIGNATURES Signatures 43 CAUTIONARY NOTE REGARDING FORWARD-LOOKI NG STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act ), about us and our industry that involve substantial risks and uncertainties.
SEC original ↗Aveanna Healthcare Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
They involve risks, uncertainties and assumptions.
SEC original ↗Aveanna Healthcare Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
Considering these risks, uncertainties and assumptions, the forward-looking statements contained in this Quarterly Report on Form 10-Q might not prove to be accurate and you should not place undue reliance upon them or otherwise rely upon them as predictions of future events.
SEC original ↗Aveanna Healthcare Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
REVENUE The Company evaluates the nature, amount, timing and uncertainty of revenue and cash flows using the five-step process .
SEC original ↗Aveanna Healthcare Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
Most contracts contain variable consideration; however, it is unlikely that a significant reversal of revenue will occur when the uncertainty is resolved, and therefore, the Company has included the variable consideration in the estimated transaction price.
SEC original ↗Aveanna Healthcare Holdings, Inc. — 10-Q Quarterly report10-QAug 13, 2026
Earnings deck slides
0 decks with slide viewAveanna Healthcare Holdings, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Aveanna Healthcare Holdings, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Aveanna Healthcare Holdings, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Aveanna Healthcare Holdings, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Aveanna Healthcare Holdings, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Aveanna Healthcare Holdings, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
36 documents- Q3 2026
- 8-KAVAH
- Q2 2026
- 8-KAVAH
- 8-KAVAH
- 8-KAVAH
- 10-QAVAH
- 8-KAVAH
- Q1 2026
- 8-KAVAH
- 8-KAVAH
- 8-KAVAH
- EX-99AVAH
- 8-KAVAH
- 8-KAVAH
- 10-QAVAH
- Q4 2025
- 8-KAVAH
- 8-KAVAH
- 10-KAVAH
- 8-KAVAH
- EX-99AVAH
- 8-KAVAH
- 8-KAVAH
- EX-99AVAH
- EX-99AVAH
- EX-99AVAH
- 8-KAVAH
- Q3 2025
- 8-KAVAH
- 8-KAVAH
- 8-KAVAH
- 10-QAVAH
- 8-KAVAH
- 8-KAVAH
- Q2 2025
- 8-KAVAH
- 8-KAVAH
- EX-99AVAH
- 8-KAVAH
- 8-KAVAH
- 10-QAVAH
Earnings releases
9 documentsPresentations
6 documents
Transcripts
0 documentsNo transcripts for Aveanna Healthcare Holdings, Inc. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.